19 results
8-K
EX-10.2
INM
InMed Pharmaceuticals Inc
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
the plural, and vice versa, the use of any term is generally applicable to either gender and, where applicable, to a corporation, the word
DEF 14A
u4qcro
28 Oct 21
Definitive proxy
3:07pm
S-8
EX-4.2
a5xax5q57lqcze3
5 Mar 21
Registration of securities for employees
12:54pm
S-1
EX-10.15
2lwaiw 6ageqc
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.9
bku oiivlg
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.14
lhe8dd1ggg 9c2dwf7d
19 Jun 20
IPO registration
4:59pm
S-1
EX-10.1
ps0l 700jw
19 Jun 20
IPO registration
4:59pm
DRS/A
EX-10.15
9nackv2o8r3hz
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
fn47 tahz
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
6ppw1rsm0296
27 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.9
e3n xfkzb
27 May 20
Draft registration statement (amended)
12:00am
DRS
EX-10.1
c1bqkaay50x5dunun
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.9
grkicob0cmrt dy5kk
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.14
epgqg8wa
13 Apr 20
Draft registration statement
12:00am
DRS
EX-10.15
u8p2e vm8
13 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next